References
- Andersson U, Wang H, Palmblad K, et al (2000). High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med, 192, 565-70. https://doi.org/10.1084/jem.192.4.565
- Bauernfeind FG, Horvath G, Stutz A, et al (2009). Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol, 183, 787-91. https://doi.org/10.4049/jimmunol.0901363
- Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44. https://doi.org/10.1038/nature07205
- Carrascal MT, Mendoza L, Valcarcel M, et al (2003). Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res, 63, 491-7.
- Eissa SA, Zaki SA, El-Maghraby et al (2005). Importance of serum IL-18 and RANTES as markers for breast carcinoma progression. J Egypt Natl Canc Inst, 17, 51-5.
- Klune JR, Dhupar R, Cardinal J, et al (2008). HMGB1: endogenous danger signaling. Mol Med, 14, 476-84.
- Lewis AM, Varghese S, Xu H, et al (2006). Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med, 4, 48. https://doi.org/10.1186/1479-5876-4-48
- Lotze MT, Tracey KJ (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol, 5, 331-42. https://doi.org/10.1038/nri1594
- Luan ZG, Zhang H, Yang PT, et al (2010). HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology, 215, 956-62. https://doi.org/10.1016/j.imbio.2009.11.001
- Martinon F (2010). Signaling by ROS drives inflammasome activation. Eur J Immunol, 40, 616-9. https://doi.org/10.1002/eji.200940168
- Merendino RA, Gangemi S, Ruello A, et al (2001). Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int J Biol Markers, 16, 126-9.
- Okamoto M, Liu W, Luo Y, et al (2010). Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem, 285, 6477-88. https://doi.org/10.1074/jbc.M109.064907
- Park JS, Gamboni-Robertson F, He Q, et al (2006). High mobility group box 1 protein interacts with multiple Tolllike receptors. Am J Physiol Cell Physiol, 290, C917-24.
- Schroder K, Tschopp J (2010). The inflammasomes. Cell, 140, 821-32. https://doi.org/10.1016/j.cell.2010.01.040
- Sha Y, Zmijewski J, Xu Z, et al (2008). HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol, 180, 2531-7. https://doi.org/10.4049/jimmunol.180.4.2531
- Sims GP, Rowe DC, Rietdijk ST, et al (2010). HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol, 28, 367-88. https://doi.org/10.1146/annurev.immunol.021908.132603
- Tang D, Kang R, 3rd ZHJ, et al (2010). High-mobility group box 1 and cancer. Biochim Biophys Acta, 1799, 131-40. https://doi.org/10.1016/j.bbagrm.2009.11.014
- Tschopp J, Schroder K (2010). NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production. Nat Rev Immunol, 10, 210-5. https://doi.org/10.1038/nri2725
- Wang P, Cong M, Liu TH, et al (2010). Primary isolated hepatic oval cells maintain progenitor cell phenotypes aftertwo-year prolonged cultivation. J Hepatol, 53, 863-71. https://doi.org/10.1016/j.jhep.2010.05.014
- Yang D, Chen Q, Yang H, et al (2007). High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol, 81, 59-66.
- Yang J, Chen L, Yang J, et al (2011). High mobility group box- 1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep, 39, 3361-7.
- Ye ZB, Ma T, Li H, et al (2007). Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma. World J Gastroenterol, 13, 1747-51. https://doi.org/10.3748/wjg.v13.i11.1747
Cited by
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke vol.4, pp.9, 2013, https://doi.org/10.1038/cddis.2013.326
- S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1 vol.8, pp.8, 2013, https://doi.org/10.1371/journal.pone.0072138
- The Emerging Role of the Receptor for Advanced Glycation End Products on Innate Immunity vol.33, pp.1, 2014, https://doi.org/10.3109/08830185.2013.849702
- The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines vol.390, pp.1-2, 2014, https://doi.org/10.1007/s11010-014-1978-6
- Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling vol.54, pp.12, 2014, https://doi.org/10.1002/mc.22231
- Microglia centered pathogenesis in ALS: insights in cell interconnectivity vol.8, pp.1662-5102, 2014, https://doi.org/10.3389/fncel.2014.00117
- Potential role of High mobility group box 1 in hepatocellular carcinoma vol.8, pp.5, 2014, https://doi.org/10.4161/19336918.2014.969139
- Adrenergic stimulation alters the expression of inflammasome components and interleukins in primary human monocytes vol.11, pp.1, 2015, https://doi.org/10.3892/etm.2015.2850
- HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients vol.13, pp.1, 2015, https://doi.org/10.1186/s12967-015-0663-1
- B cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice vol.24, pp.6, 2015, https://doi.org/10.1111/exd.12685
- Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells vol.67, pp.5, 2015, https://doi.org/10.1002/iub.1379
- Production vol.2016, pp.1466-1861, 2016, https://doi.org/10.1155/2016/5460302
- Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development vol.241, pp.3, 2016, https://doi.org/10.1002/path.4848
- Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke vol.10, pp.11, 2017, https://doi.org/10.1002/jbio.201600244
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis vol.233, pp.3, 2018, https://doi.org/10.1002/jcp.25930
- Leukocytapheresis for the treatment of acute exacerbation of idiopathic interstitial pneumonias: a pilot study vol.64, pp.1.2, 2017, https://doi.org/10.2152/jmi.64.110
- Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease vol.9, pp.4, 2017, https://doi.org/10.3390/nu9040385
- Evidence that NF-κB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke pp.1559-1182, 2017, https://doi.org/10.1007/s12035-017-0394-9
- Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector? vol.22, pp.13, 2015, https://doi.org/10.1089/ars.2014.5994
- HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome vol.9, pp.1664-042X, 2018, https://doi.org/10.3389/fphys.2018.00313
- Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance vol.2018, pp.1942-0994, 2018, https://doi.org/10.1155/2018/4321714